PharmaKinetics
Executive Summary
Baltimore-based contract testing lab said Nov. 14 that is will file for Chapter 11 protection in Baltimore federal bankruptcy court. The move follows by one week a company reorganization under which Steven Woodman relinquished his CEO role to Brewster Jones, and the termination of negotiations for a sale of the company's U.S. operation to Applied Bioscience International ("The Pink Sheet" Nov. 12, T&G-10).